The Operating Theatre Journal

Saturday, 13 July 2013

Ondansetron for intravenous use: dose-dependent QT interval prolongation—new posology

http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON296402

No comments:

Post a Comment